| 000 | 02714 a2200769 4500 | ||
|---|---|---|---|
| 005 | 20250516174213.0 | ||
| 264 | 0 | _c20140123 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2012.48.3685 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArmand, Philippe | |
| 245 | 0 | 0 |
_aDisabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2013 |
||
| 300 |
_a4199-206 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aChile |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aFatigue _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
| 650 | 0 | 4 | _aIndia |
| 650 | 0 | 4 | _aIsrael |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xetiology |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNagler, Arnon | |
| 700 | 1 | _aWeller, Edie A | |
| 700 | 1 | _aDevine, Steven M | |
| 700 | 1 | _aAvigan, David E | |
| 700 | 1 | _aChen, Yi-Bin | |
| 700 | 1 | _aKaminski, Mark S | |
| 700 | 1 | _aHolland, H Kent | |
| 700 | 1 | _aWinter, Jane N | |
| 700 | 1 | _aMason, James R | |
| 700 | 1 | _aFay, Joseph W | |
| 700 | 1 | _aRizzieri, David A | |
| 700 | 1 | _aHosing, Chitra M | |
| 700 | 1 | _aBall, Edward D | |
| 700 | 1 | _aUberti, Joseph P | |
| 700 | 1 | _aLazarus, Hillard M | |
| 700 | 1 | _aMapara, Markus Y | |
| 700 | 1 | _aGregory, Stephanie A | |
| 700 | 1 | _aTimmerman, John M | |
| 700 | 1 | _aAndorsky, David | |
| 700 | 1 | _aOr, Reuven | |
| 700 | 1 | _aWaller, Edmund K | |
| 700 | 1 | _aRotem-Yehudar, Rinat | |
| 700 | 1 | _aGordon, Leo I | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 31 _gno. 33 _gp. 4199-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2012.48.3685 _zAvailable from publisher's website |
| 999 |
_c23172923 _d23172923 |
||